To read this article in full you will need to make a payment
Purchase one-time access
Or purchase The Lancet Choice
Access any 5 articles from the Lancet Family of journals
Subscribe to The Lancet Psychiatry
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
Prevalence and correlates of marijuana use in Canada, 2012.
Health Rep. 2015; 26: 10-15
Trends in cannabis use over time among Canadian youth: 2004–14.
Prev Med. 2018; 118: 30-37
US epidemiology of cannabis use and associated problems.
Neuropsychopharmacology. 2018; 43: 195-212
Minimal physical health risk associated with long-term cannabis use: but buyer beware.
JAMA. 2016; 315: 3228-3229
Cannabis legalization and psychiatric disorders: caveat “hemp-tor”.
Can J Psychiatry. 2018; 63: 447-450
Adverse health effects of marijuana use.
N Engl J Med. 2014; 370: 2219-2227
Association of cannabis with cognitive functioning in adolescents and young adults: a systematic review and meta-analysis.
JAMA Psychiatry. 2018; 75: 585-595
Understanding the link between cannabinoids and psychosis.
Clin Pharmacol Ther. 2017; 101: 197-199
Cannabis and mood disorders.
Curr Addict Rep. 2018; 5: 336-345
Recreational cannabis legalisation: details will determine mental health effects.
Lancet Psychiatry. 2016; 3: 798-799
The health effects of cannabis and cannabinoids: current state of evidence and recommendations for research.
The National Academies Press, Washington, DC; 2017
Article Info
Publication History
Published: January 2019
IDENTIFICATION
Copyright
© 2018 Elsevier Ltd. All rights reserved.
